BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 1, 2014
View Archived Issues
Hydrogel-based inhibitor delivery system developed to prevent adverse cardiac remodeling
Read More
Roche divulges new agents for HBV infection
Read More
Idera Pharmaceuticals reports topline data from phase II trial of IMO-8400
Read More
Fujifilm and Center for iPS Cell Research initiate collaboration on T-817MA
Read More
Amgen presents new GK-GKRP disruptors for type 2 diabetes
Read More
Quidel receives FDA clearance for AmpliVue HSV 1+2 assay
Read More
Meridian Biosciences' illumigene Pertussis test cleared by the FDA
Read More
FDA committee recommends approval of Cologuard colorectal cancer screening test
Read More
Japan Vaccine seeks approval of pediatric pneumococcal conjugate vaccine in Japan
Read More
Phase IIb topline results reported for cariprazine in bipolar depression
Read More
FDA grants orphan drug status to NHL treatments
Read More
Takeda licenses Trianni transgenic mouse antibody discovery platform
Read More
Eisai assigns Dacogen rights to Otsuka Pharmaceutical
Read More
Janssen Pharmaceutical discloses novel fatty acid synthase inhibitors
Read More
New MPS1 inhibitors presented by Cancer Research Technology
Read More
Japanese researchers design new MetAP 2 inhibitors
Read More
Reata Pharmaceuticals divulges new NO production inhibitors
Read More
Bristol-Myers Squibb presents new agent for thrombosis
Read More
New agents for dengue virus disclosed by SIGA Technologies
Read More
e-Therapeutics reports interim results from phase Ia trial of ETS-2101
Read More
CytRx's aldoxorubicin receives orphan medicinal product designation in Europe
Read More
GSK withdraws request for a variation to Votrient's marketing authorization
Read More
FDA lifts partial clinical hold on CUDC-427
Read More
Shire submits Intuniv MAA to EMA
Read More
NIH funds flavivirus research at The Scripps Research Institute
Read More
FDA advisory committee recommends approval of dalbavancin for ABSSSI
Read More
Tedizolid phosphate recommended for FDA approval for skin infections
Read More